PROGNOSTIC VALUE OF MOLECULAR PHENOTYPES IN ANAPLASTIC GLIOMA PATIENTS WITH PROLONGED ADMINISTRATION OF TEMOZOLOMIDE

被引：0
|
作者：
Kong, Doo-Sik [1 ,2 ]
Choi, Yoon-La [1 ]
Seol, Ho Jun [1 ]
Lee, Jung-Il [1 ]
Nam, Do-Hyun [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide
    Kong, Doo-Sik
    Kim, Hong Rye
    Choi, Yoon-Ra
    Seol, Ho Jun
    Lee, Jung-Il
    Nam, Do-Hyun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (09) : 1425 - 1429
  • [2] Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma
    Freyschlag, C. F.
    Smolczyk, D. R.
    Janzen, E.
    Schmieder, K.
    Thome, C.
    Lohr, F.
    Wenz, F.
    Weiss, C.
    Tuettenberg, J.
    Seiz, M.
    ANTICANCER RESEARCH, 2011, 31 (11) : 3873 - 3877
  • [3] Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide
    Nandipati, Sirisha
    Demopoulos, Alexis
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 663 - 665
  • [4] Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide
    Sirisha Nandipati
    Alexis Demopoulos
    Journal of Neuro-Oncology, 2011, 105 : 663 - 665
  • [5] Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
    Lopci, Egesta
    Riva, Marco
    Olivari, Laura
    Raneri, Fabio
    Soffietti, Riccardo
    Piccardo, Arnoldo
    Bizzi, Alberto
    Navarria, Pierina
    Ascolese, Anna Maria
    Ruda, Roberta
    Fernandes, Bethania
    Pessina, Federico
    Grimaldi, Marco
    Simonelli, Matteo
    Rossi, Marco
    Alfieri, Tommaso
    Zucali, Paolo Andrea
    Scorsetti, Marta
    Bello, Lorenzo
    Chiti, Arturo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (07) : 1155 - 1164
  • [6] Prognostic value of molecular and imaging biomarkers in patients with brainstem glioma
    Wu, Yuliang
    Zhao, Xiaobin
    Pan, Changcun
    Zhang, Peng
    Sun, Yu
    Chen, Xin
    Xiao, Xiong
    Geng, Yibo
    Zuo, Pengcheng
    Ai, Lin
    Zhang, Liwei
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [7] Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
    Egesta Lopci
    Marco Riva
    Laura Olivari
    Fabio Raneri
    Riccardo Soffietti
    Arnoldo Piccardo
    Alberto Bizzi
    Pierina Navarria
    Anna Maria Ascolese
    Roberta Rudà
    Bethania Fernandes
    Federico Pessina
    Marco Grimaldi
    Matteo Simonelli
    Marco Rossi
    Tommaso Alfieri
    Paolo Andrea Zucali
    Marta Scorsetti
    Lorenzo Bello
    Arturo Chiti
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1155 - 1164
  • [8] Prognostic value of MGMT methylation and expression in malignant glioma patients treated with adjuvant temozolomide chemotherapy
    Loeser, S. C.
    Blaschke, B.
    Koehler, S.
    Kreuzmann, A.
    Rapp, M.
    Goeppert, M.
    Reifenberger, G.
    Sabel, M.
    ACTA NEUROPATHOLOGICA, 2006, 112 (03) : 375 - 375
  • [9] The prognostic value of MGMT promoter hypermethylation and other genetic markers in malignant glioma patients treated with temozolomide
    Sabel, M.
    Loeser, S.
    Luyken, C.
    Willers, R.
    Willers, R.
    Rapp, M.
    Reifenberger, G.
    NEURO-ONCOLOGY, 2006, 8 (04) : 326 - 326
  • [10] Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Siker, Malika L.
    Chakravarti, Arnab
    Mehta, Minesh P.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (02) : 99 - 111
12345